Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,237 across all filing types
Latest filing 2026-02-17 Notice of Dividend Amou…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
General Updates
Notice of Dividend Amount Classification · 95% confidence The document is a communication to shareholders regarding the tax deduction at source (TDS) on an interim dividend declared for the financial year 2025-2026. It details the tax provisions, eligibility, and documentation required for shareholders to claim tax exemption or withholding tax at prescribed rates. The document references the declaration of an interim dividend by the Board of Directors and provides instructions and annexures related to tax forms and compliance. It is not a financial report, earnings release, or regulatory filing about a change in management or capital structure. It is also not a notice of dividend amount per se, but rather a detailed communication about tax deduction on the interim dividend. Given the content and purpose, this document best fits the category of Notice of Dividend Amount (DIV), as it relates to dividend declaration and associated shareholder information about tax deduction on that dividend. The document length and detail confirm it is not a brief announcement but a substantive communication to shareholders about dividend tax matters.
2026-02-17 English
Please find enclosed herewith the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10, 2026.
Notice of Dividend Amount Classification · 95% confidence The document is a communication to shareholders regarding the tax deduction at source (TDS) on an interim dividend declared for the financial year 2025-2026. It details the tax provisions, documentation requirements, and deadlines related to withholding tax on dividend payments. The document references the declaration of an interim dividend by the Board of Directors and provides instructions and explanations about tax deduction procedures. It does not contain financial statements or results but is an announcement related to dividend payment and tax withholding. Therefore, it fits the category of Notice of Dividend Amount (DIV), as it announces dividend details and related tax information to shareholders.
2026-02-17 English
The Company wishes to clarify the news item that appeared in CNBC Awaaz today, i.e. February 13, 2026. Please find attached herewith Clarification Letter.
Regulatory Filings Classification · 95% confidence The document is a clarification letter addressed to stock exchange listing departments regarding a speculative news item about the company. It explicitly states that no official decision or arrangement has been made and that no disclosure is warranted under SEBI regulations. The content is a regulatory announcement clarifying misinformation rather than a financial report, management change, or other specific filing. The document length is short (2157 characters) and serves as a regulatory disclosure under SEBI Listing Obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-13 English
Rumour Verification - Regulation 30(11)
Regulatory Filings Classification · 95% confidence The document is a clarification letter addressed to stock exchange listing departments regarding a speculative news item about the company. It explicitly states that no official decision or arrangement has been made and that no disclosure is warranted under SEBI regulations. The content is a regulatory announcement clarifying misinformation rather than a financial report, management change, or other specific filing. The document length is short (2157 characters) and serves as a regulatory disclosure under SEBI Listing Obligations, fitting the category of a general regulatory announcement. Therefore, it best fits the Regulatory Filings (RNS) category.
2026-02-13 English
The Company wishes to clarify the news item that appeared in CNBC Awaaz today, i.e. February 13, 2026. Please find attached herewith the Clarification Letter.
Regulatory Filings Classification · 95% confidence The document is a clarification letter addressed to stock exchanges regarding a speculative news item about a potential business arrangement. It explicitly states that no decision or arrangement has been finalized or approved, and no information warrants disclosure under SEBI regulations. The document is a regulatory communication clarifying misinformation rather than a financial report, earnings release, or any formal announcement of corporate actions. It does not contain financial data, management discussion, or report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-02-13 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.